Mesoblast Reports Operational and Financial Highlights for
NEW YORK, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic
Globe Newswire28-02-2023, 05:20
Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors 28-03-2024, 17:00